Our Funds

Parnassus Fund

 

Ticker: PARNX

As of March 31, 2013, the net asset value per share ("NAV") of the Parnassus Fund was $42.97, so the total return for the quarter was 5.79%. This compares to 10.61% for the S&P 500 Index ("S&P 500") and 10.44% for the Lipper Multi-Cap Core Average, which represents the average multi-cap core fund followed by Lipper ("Lipper average"). Normally, I'd be delighted with a return of almost 6% for a quarter, but this quarter, it doesn't look too good in comparison with our benchmarks. The market moved sharply higher, but technology and telecommunications did not do as well as the market as a whole. As you will read in the company analysis section, three of the stocks that hurt us the most were related to software and telecommunications. I think these three companies are significantly undervalued and I believe they will bounce back before long.

Below is a table comparing the Parnassus Fund with the S&P 500 and the Lipper average over the past one-, three-, five- and ten-year periods. For the one-year period, we're ahead of the Lipper average, but we lag the S&P 500 because of our relatively weak performance for the quarter. The same thing applies to the three-year numbers. We are well ahead of both benchmarks for the five-year period. We are, however, slightly behind the benchmarks for the ten-year period, primarily because some of our best relative performance (in 2000, 2001 and early 2002) have dropped out of the ten-year numbers, leaving some of our worst relative performance periods (in late 2003 and 2004) to lower the ten year average.

parnx returns

Performance data quoted represent past performance and are no guarantee of future returns. Current performance may be lower or higher than the performance data quoted. Current performance information to the most recent month-end is available on the Parnassus website (www.parnassus.com). Investment return and principal value will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original principal cost. Returns shown in the table do not reflect the deduction of taxes a shareholder may pay on fund distributions or redemption of shares. The S&P 500 Composite Stock Index (also known as the S&P 500) is an unmanaged index of common stocks, and it is not possible to invest directly in an index. Index figures do not take any expenses, fees or taxes into account, but mutual fund returns do. Prior to May 1, 2004, the Parnassus Fund charged a sales load (maximum of 3.5%), which is not reflected in the total return calculations.

Before investing, an investor should carefully consider the investment objectives, risks, charges and expenses of the Fund and should carefully read the prospectus or summary prospectus, which contain this and other information. The prospectus or summary prospectus can be obtained on the Parnassus website, or by calling (800) 999-3505. As described in the Fund's current prospectus dated May 1, 2013, Parnassus Investments has contractually agreed to limit the total operating expenses to 0.99% of net assets, exclusive of acquired fund fees, until May 1, 2014. This limitation may be continued indefinitely by the Adviser on a year-to-year basis.

Company Analysis

Three companies sliced 19¢ or more off the value of each Parnassus share for the quarter. Finisar caused the most damage, cutting 34¢ off the NAV, as its stock dropped 19.1% from $16.30 to $13.19. The company makes optical equipment used in telecommunications, and its customers delayed investing in additional network capacity, because they are hesitant to commit significant sums of money until the economy strengthens. Because Internet traffic continues to have strong growth, at some point telecommunications companies will have to make substantial new investments in network capacity, and at that point, Finisar sales should move much higher and so will the stock.

Riverbed Technology also knocked 34¢ off the NAV, as it sank 24.4% during the quarter from $19.72 to $14.91. The company makes software for use in optimizing wide-area networks (WANs), which speed the flow of information within an organization from site-to-remote-site. The stock dropped after management reduced its earnings outlook for the upcoming quarter, citing sluggish public sector demand for its core WAN product and higher integration costs from its recent acquisition of OPNET Technologies. We expect demand for Riverbed's core WAN optimization software will rebound, as trends toward mobile computing and virtualized workplaces drive greater data traffic across wide-area networks. New product releases and merger synergies should also boost profits next year.

EZchip Semiconductor, a designer of semiconductors used in data centers, enterprise networks and telecommunications equipment, saw its stock drop 27% during the quarter, from $33.07 to $24.13 for a loss of 19¢ per fund share. EZchip reduced its long-term revenue outlook after one of its customers, Huawei, decided to design its own semiconductors rather than purchase from EZchip. Investors are worried that other customers may begin to design their own chips. Although this is a risk, we think that EZchip's technology is of such a high quality, and the costs to switch are so great, that the company will remain the undisputed leader in network-processors. After the drop in price, the stock is trading at its lowest valuation in two years.

Four portfolio companies each added 19¢ or more to each fund share. The biggest winner was Applied Materials, which added 35¢ to the NAV, as its stock climbed 17.8% from $11.44 to $13.48. The company is the biggest maker of semiconductor manufacturing equipment, selling to large chipmakers like Intel and Taiwan Semiconductor Manufacturing. Customers are increasing capacity to build chips for the growing markets for smartphones and tablets.

Shares of Charles Schwab, the San Francisco-based bank and brokerage firm, jumped 23.2% from $14.36 to $17.69 during the quarter, contributing 33¢ to each fund share. Although earnings increased modestly in the first quarter, the driving force was not net income, but rather an expected increase in interest rates. Interest rates, of course, are still very low, but as the economy improves, investors anticipate higher rates, and this was enough to move Schwab's stock higher. There are three ways that Schwab will make more money with rising rates. First, it will increase the interest earned on margin loans. Second, it will increase the interest earned on loans made by the Schwab Bank. Third, it will enable Schwab to earn a full fee on managing its money market funds. Because of low interest rates, Schwab had to waive most of its fees on these funds, which last year amounted to $587 million.

Gilead Sciences, a biotech company specializing in medicine to treat HIV and liver diseases, added 27¢ to the NAV and rose 19.8% from $36.73 to $44.01, where we sold it during the quarter, because of significant increases in the share price. Stribild, the company's new once-a-day HIV pill that produces higher viral suppression with fewer side effects, doubled in total prescriptions from year-end 2012 to mid-March of 2013. parnx compositionGilead also continued to have success developing Sofosbuvir (previously called GS-7977), producing more clinical trial data demonstrating the drug's effectiveness in curing hepatitis C across different and often difficult-tocure patient populations. Like Stribild, Sofosbuvir is a more effective treatment and better tolerated than its competition.

Shares of homebuilder DR Horton rose 22.9% from $19.78 to $24.30, contributing 19¢ to each fund share. The stock jumped after the company reported that its quarterly earnings increased by 122%, well above expectations, as both the number of homes sold and the average selling price increased. The housing market continues to improve, and Horton's broad geographic base and strong balance sheet enabled the company to reap strong earnings. Chairman Donald R. Horton stated in the earnings release that "DR Horton is in the best position it has ever been in its 35-year history," and the company's performance backs that up.

Outlook and Strategy

Note: This section represents my thoughts and applies to the three funds that I manage: the Parnassus Fund, the Parnassus Small-Cap Fund and the Parnassus Workplace Fund. The other portfolio managers discuss their thoughts in their respective reports.

The last time I discussed outlook and strategy was three months ago, in the annual report for 2012, and I was talking about the great performance my three funds had for the year. Unfortunately, I can't brag about our performance in the current quarter, so it's been a humbling experience. In the last report, I said that housing stocks had powered our performance, but that it was unlikely that they would continue moving ahead at that speed in 2013. Instead, I indicated that technology and telecommunications might be the big winners in 2013.

So far, that hasn't happened. While Applied Materials helped the Parnassus Fund and the Workplace Fund, and PMC-Sierra helped the Small-Cap Fund, most technology and telecommunications stocks hurt our performance. Finisar, Riverbed and EZchip cut significant value off the NAV of the Parnassus Fund and the Small-Cap Fund; Riverbed also subtracted a lot of value from each share of the Workplace Fund.

That's the bad news. The good news is that I think our technology and telecom names have a lot more value than indicated in their current quotations. I expect them to make positive contributions before the year is out.

The economy is clearly recovering, and the stock market is reflecting that recovery. However, stock market indices have come a long way in a short period of time. My feeling is that we could have a correction before long. There might be a sharp decline, but if it were to happen, I think it would only be a temporary phenomenon. The recovery may be rocky, but I believe we'll continue to see more strength in the housing market, and this should help employment and manufacturing.

Despite the run-up in the stock market, I don't think that the shares in our portfolios are overvalued. All three of the funds that I manage are positioned for a strong recovery. My views still haven't changed from the last report, when I said that technology and telecommunications shares could drive strong performance in 2013. I also expect financial shares to help us as the year unfolds.

Thank you very much for investing in the Parnassus Funds.

Yours truly,

dodson signature
Jerome L. Dodson
Portfolio Manager

The information above represents the Letter from Parnassus Investments, management's discussion and analysis of fund performance, and Responsible Investing Notes as excerpted from the Report. Please click on the "Full Report" link above to view the Report in its entirety.

Note on Internet Explorer 6